from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3377c/-

LFCtreatmentdescriptionclass of inhibitor

0.316

Amikacinug/mL Amikacintranslation

-0.085

Cap5-10ug/mL Capreomycintranslation

-0.755

Rox10-50 ug/mL Roxithromycintranslation

-0.089

SM2-5 ug/mL Streptomycintranslation

-1.262

Tet5-10 ug/mL Tetracyclinetranslation

0.252

Rif0.2-5ug/mL Rifampicintranscription

1.277

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.165

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.659

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.652

CPZ10-50 ug/mL Chlorpromazinerespiration

0.197

Clofazimine10-13 ug/mL Clofaziminerespiration

0.967

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.333

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.082

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.724

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.658

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.399

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.518

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.025

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.221

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.283

KCN5-20 ug/mL Potassium cyaniderespiration

0.285

NaN30.2-2 mM Sodium aziderespiration

0.131

Nigericin50 uM Nigericinrespiration

-0.602

TRC10-150 ug/mL Triclosanrespiration

-1.236

TRZ10-25 ug/mL Thioridazinerespiration

0.017

Valinomycin0.5-10 uM Valinomycinrespiration

1.629

ZnSO42 mM ZnSO4respiration

-0.964

menadione6-10 ug/mL Menadionerespiration

-0.029

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.746

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.461

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.772

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.884

NRP_1Non-replicating persistence stage 1dosRassociated

0.752

Amp0.2mg/mL AmpicillincellWall

-0.126

Cephalexin20-100 ug/mL CephalexincellWall

-0.232

Cerulenin0.32-5 ug/mL CerulenincellWall

0.146

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.253

EMB10-20 ug/mL EthambutolcellWall

-0.043

Eta12-40 ug/mL EthionamidecellWall

0.746

INH0.2-0.4 ug/mL IsoniazidcellWall

0.493

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.619

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.922

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.570

BZA0.12 mg/mL BenzamidearomaticAmides

-0.144

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.233

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.083

H2O24 mM hydrogen peroxideDNAdamaging

0.218

Levo10 ug/mL LevofloxacinDNAdamaging

0.049

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.192

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.492

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.312

UVUV-irradiationDNAdamaging

-1.508

ARP41-4 ug/mL Antitubercular compound ARP4?

0.580

Antimycin12.5-50 ug/mL Antimycin A?

0.900

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.578

PA_110-50 ug/mL Antitubercular compound PA-1?

0.226

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.899

PA8240.2-2 ug/mL PA-824?

-0.349

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.479

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.970

Verapamil50 uM Verapamil?

1.093

mercaptoethanol2 mM 2-Mercaptoethanol?

0.552

methoxatin10-20 ug/mL Methoxatin?